Effective April 21:
Naproxen sodium 220 mg per oral dosage unit (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes exceeding 6,600 mg) is now Schedule III (changed from Schedule II).
Succession planning: the search is on for new ACP registrar
May 14, 2024
Council approves specifications for registrar’s position.
Read more ➞
